Contact
Contact page
Category & trade
Primary
infectious-diseases · embed-ft 0.6
Tree path
Medical Health › Diseases and Conditions › Infectious Diseases
Group (tier-1)
Tech stack
CDN
AI readiness
AI-Readiness score
44 / 100 · partial · see similar
AI training policy
allowed
AI-bot protection
AI files
Compliance (GEO / GDPR)
TLD
Overview
Title
LB6V Lyme Disease Vaccine — Phase 3 VALOR Results | LB6V Info
Description
LB6V (PF-07307405), the Pfizer/Valneva Lyme disease vaccine, demonstrated >70% efficacy in Phase 3. Learn about the science, trial results, and who could benefit.
Final URL
Language
en (html)
Scanned at
2026-07-17 15:52:41